EMA Authorised: Invega (paliperidone) — Janssen-Cilag International NV

View source ↗

Summary

The EMA authorised Invega (paliperidone) from Janssen-Cilag International NV for schizophrenia and related psychotic disorders. This marks its marketing authori…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorders
• Schizophrenia

Drugs mentioned

• INVEGA (PALIPERIDONE)

Snippet

Status: Authorised. Therapeutic area: Schizophrenia;Psychotic Disorders. MAH: Janssen-Cilag International NV. Decision date: 09/07/2024